Choong-wae completes Phase 2 trial of avanafil

Published: 2008-11-12 06:51:00

Updated: 2008-11-12 06:51:00

Choong-wae Pharm says its has recently completed Phase 2 study of avanafil, Japan Tanabe’s phosphodiesterase type 5, or PDE5, inhibitor product candidate for the treatment of erectile dysfunction.

The trial took nine months from January in eight university hospitals, including Seoul National U...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK